Edesa Biotech (EDSA) News Today $2.10 -0.10 (-4.55%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Edesa Biotech Gains CEO’s Strategic Investment BoostNovember 1, 2024 | markets.businessinsider.comEdesa Leaps as CEO Boosts HoldingsOctober 31, 2024 | baystreet.caEdesa Biotech’s Founder Makes Strategic Investment in the CompanyOctober 31, 2024 | markets.businessinsider.comEdesa Biotech's Founder Makes Strategic Investment in the CompanyOctober 31, 2024 | globenewswire.comEdesa Biotech to Present at Global ConferencesOctober 22, 2024 | markets.businessinsider.comEdesa Biotech Announces Upcoming Conference ScheduleOctober 21, 2024 | globenewswire.comPardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.September 13, 2024 | globenewswire.comEDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024August 9, 2024 | investorplace.comEdesa Biotech Reports Fiscal 3rd Quarter 2024 ResultsAugust 9, 2024 | globenewswire.comEDSA: Preparing IND for Phase 2 Trial of EB06 in VitiligoMay 28, 2024 | finance.yahoo.comEDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024May 10, 2024 | investorplace.comInsider Buying: Edesa Biotech, Inc. (NASDAQ:EDSA) CEO Acquires 5,000 Shares of StockMarch 26, 2024 | insidertrades.comEDSA: Development of EB05 in ARDS Continues…February 15, 2024 | finance.yahoo.comEdesa Biotech Inc (EDSA)February 14, 2024 | investing.comEdesa Biotech Stock (NASDAQ:EDSA) Earnings Dates and Earning CallsFebruary 11, 2024 | benzinga.comEdesa Biotech Reports Fiscal 1st Quarter 2024 ResultsFebruary 9, 2024 | finance.yahoo.comEDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…January 2, 2024 | finance.yahoo.comEdesa Biotech Reports Fiscal Year 2023 ResultsDecember 15, 2023 | finance.yahoo.comTrading was temporarily halted for "EDSA" at 12:12 PM with a stated reason of "LULD pause."December 12, 2023 | marketbeat.comEdesa Biotech Stock (NASDAQ:EDSA) Dividends: History, Yield and DatesDecember 1, 2023 | benzinga.comEdesa Biotech Inc EDSANovember 12, 2023 | morningstar.comEdesa Biotech (EDSA) Price Target Increased by 528.00% to 53.38November 2, 2023 | msn.comEdesa Biotech to Present at Dermatology Drug Development SummitOctober 26, 2023 | finance.yahoo.comRegulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS DrugOctober 25, 2023 | finance.yahoo.comEDSA: Secures up to CAD$23 Million to Fund Development of EB05…October 19, 2023 | finance.yahoo.comTrading was temporarily halted for "EDSA" at 09:10 AM with a stated reason of "LULD pause."October 13, 2023 | marketbeat.comWhy Is Infectious Disease Player Edesa Biotech Stock Soaring Today?October 12, 2023 | msn.comEdesa Biotech to Receive Up To C$23 Million in Funding from Federal GovernmentOctober 12, 2023 | finance.yahoo.comEdesa Biotech Secures $10 Million Credit Facility with Company FounderOctober 12, 2023 | finance.yahoo.comTrading was temporarily halted for "EDSA" at 12:10 PM with a stated reason of "LULD pause."October 12, 2023 | marketbeat.comEdesa Biotech falls after 1-for-7 reverse stock split announcementOctober 11, 2023 | seekingalpha.comEdesa Biotech Falls to 52-Week Low on Reverse Split NewsOctober 10, 2023 | marketwatch.comEdesa Biotech Announces One-for-Seven Reverse Share SplitOctober 10, 2023 | finance.yahoo.comEdesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug CandidateSeptember 28, 2023 | finance.yahoo.comEDSA: EB05 Inhibits Inflammation Initiated by Multiple Pathogens In Vitro…August 16, 2023 | finance.yahoo.comHC Wainwright & Co. Maintains Edesa Biotech (EDSA) Buy RecommendationAugust 15, 2023 | msn.comEdesa Biotech Reports Fiscal Third Quarter 2023 ResultsAugust 9, 2023 | finance.yahoo.comEdesa Biotech to Participate in Upcoming Canaccord Genuity Growth ConferenceJuly 27, 2023 | finance.yahoo.comEdesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical StudiesJune 28, 2023 | msn.comEdesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other PathogensJune 28, 2023 | finance.yahoo.comEdesa Biotech Anti-Inflammatory Drug Candidate Assigned NameJune 15, 2023 | finance.yahoo.comHC Wainwright & Co. Reiterates Edesa Biotech (EDSA) Buy RecommendationMay 24, 2023 | msn.comEdesa Biotech (EDSA) Earnings Dates & ReportsMay 19, 2023 | investing.comEDSA: FDA Agrees on Primary Endpoint for Phase 3 ARDS Drug Study…May 17, 2023 | finance.yahoo.comEdesa Biotech GAAP EPS of -$0.12 beats by $0.05May 12, 2023 | msn.comEdesa Biotech Reports Fiscal 2nd Quarter 2023 ResultsMay 11, 2023 | finance.yahoo.comEdesa Biotech to Participate in Swiss Biotech DayApril 20, 2023 | finance.yahoo.comEdesa Biotech: The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug CandidateApril 4, 2023 | finanznachrichten.deThe WHO and USAN Adopt Generic Name for Edesa's ARDS Drug CandidateApril 4, 2023 | finance.yahoo.comEdesa Biotech, Inc. (EDSA)March 25, 2023 | uk.finance.yahoo.com Get Edesa Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter. Email Address 📉 Warning: Market Crash Predicted - Secure Your Savings (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%. Take these 4 steps to protect your retirement here >>> EDSA Media Mentions By Week EDSA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EDSA News Sentiment▼1.430.56▲Average Medical News Sentiment EDSA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EDSA Articles This Week▼20▲EDSA Articles Average Week Get Edesa Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CELU News Today VRCA News Today DARE News Today ELEV News Today MRKR News Today EYEN News Today LGVN News Today ACST News Today ALGS News Today LIAN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EDSA) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edesa Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
